European Union - English - EMA (European Medicines Agency)

inceptua ab - ocriplasmin - retinal diseases - ophthalmologicals - jetrea is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

Singapore - English - HSA (Health Sciences Authority)

alcon pte ltd - ocriplasmin - injection, solution, concentrate - 0.5mg/0.2ml

Canada - English - Health Canada

thrombogenics nv - ocriplasmin - solution - 2.5mg - ocriplasmin 2.5mg - eent drugs, miscellaneous

Canada - English - Health Canada

thrombogenics nv - ocriplasmin - solution - 1.25mg - ocriplasmin 1.25mg - eent drugs, miscellaneous

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

thrombogenics n.v. - ocriplasmin - solution for injection - 1.25mg/1ml

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmaco (nz) ltd - ocriplasmin 2.5 mg/ml - concentrate for injection - 2.5 mg/ml - active: ocriplasmin 2.5 mg/ml excipient: citric acid monohydrate mannitol sodium hydroxide water for injection - jetrea is indicated in adults for the treatment of vitreomacular traction (vmt), including when associated with macular hole of diameter less than or equal to 400 microns.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

alcon eye care ltd - ocriplasmin - solution for injection - 2.5mg/1ml